Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine. [Corrigendum]
Nanda K, Moss AC.Clinical Pharmacology: Advances and Applications. 2012, 4:41–50.The authors apologize for errors on Tables 1, 2, and 3.Table1Citation 40, Hussain et al, should have been citation 44, Shire US Inc.Table 2Lichtenstein et al data, the confidence interval (CI) of the odds rati...
Saved in:
Main Authors: | Nanda K (Author), Moss AC (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine
by: Nanda K, et al.
Published: (2012) -
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials
by: Pierce D, et al.
Published: (2014) -
Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
by: Maconi G, et al.
Published: (2021) -
Maintaining remission in ulcerative colitis – role of once daily extended-release mesalamine
by: Lilliana Oliveira, et al.
Published: (2011) -
Randomized clinical trial: pharmacokinetics and safety of multimatrix mesalamine for treatment of pediatric ulcerative colitis
by: Cuffari C, et al.
Published: (2016)